DVA DAVITA INC.
Services-Misc Health & Allied Services, NEC · NYSE · SEC CIK 927066 · Fiscal year ends 12/31
Financial factors as of 2025-06-30 (2025Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY5.1%
TTM net income YoY-2.7%
TTM EPS YoY8.0%
Revenue 3-yr CAGR4.2%
Net income 3-yr CAGR0.1%
Margins
Gross margin—
Operating margin15.8%
Net margin6.4%
FCF margin9.8%
EBITDA margin21.1%
Returns
ROE635.3%
ROA4.8%
ROIC (approx.)18.2%
Asset turnover0.76x
Leverage & solvency
Liabilities / assets91.1%
Debt / equity—
Current ratio1.39x
Interest coverage4.00x
Cash quality & payout
Operating cash flow / net income2.23x
Accruals ratio-5.9%
Payout ratio—
Capex / revenue4.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $3.58B | $3.55B | $3.42B | $3.62B | $3.42B | $3.38B | $3.22B | $3.29B |
| SG&A expense | $408.70M | $423.46M | $421.91M | $472.36M | $414.37M | $412.81M | $374.09M | $414.48M |
| Operating income | $499.25M | $579.00M | $481.89M | $561.07M | $505.77M | $537.84M | $438.94M | $565.36M |
| Interest expense | $150.02M | $150.26M | $145.13M | $108.25M | $150.56M | $146.06M | $135.06M | $103.45M |
| Pretax income | $358.71M | $435.01M | $341.23M | $382.76M | $308.80M | $368.93M | $286.33M | $413.73M |
| Income tax | $89.32M | $91.79M | $66.20M | $76.73M | $68.55M | $93.71M | $54.12M | $64.49M |
| Net income | $222.93M | $265.40M | $197.53M | $234.22M | $150.33M | $199.34M | $162.92M | $259.33M |
| EBITDA | $664.44M | $746.81M | $659.72M | $740.68M | $683.26M | $712.54M | $615.39M | $732.00M |
| EPS (basic) | 3.49 | 4.10 | 2.93 | — | 2.09 | 2.62 | 2.05 | — |
| EPS (diluted) | 3.40 | 4.02 | 2.87 | — | 2.04 | 2.58 | 2.00 | — |
| Weighted avg. shares (diluted) | 65.50M | 66.09M | 68.88M | — | 73.77M | 77.36M | 81.28M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $495.63M | $668.96M | $644.24M | $676.44M | $795.41M | $796.96M | $524.57M | $879.83M |
| Short-term investments | $70.67M | $19.91M | $22.30M | $24.30M | $30.52M | $31.01M | $73.16M | $51.06M |
| Receivables | $2.51B | $2.47B | $2.46B | $2.41B | $2.33B | $2.44B | $2.32B | $2.15B |
| Inventory | $161.46M | $151.53M | $141.61M | $160.63M | $139.09M | $146.29M | $150.52M | $134.56M |
| Current assets | $4.07B | $4.19B | $4.06B | $4.06B | $4.11B | $4.09B | $3.64B | $3.75B |
| PP&E, net | $2.73B | $2.75B | $2.75B | $2.81B | $2.85B | $2.85B | $2.90B | $2.94B |
| Goodwill | $7.55B | $7.59B | $7.58B | $7.55B | $7.54B | $7.47B | $7.42B | $7.38B |
| Intangibles | $221.07M | $228.82M | $229.02M | $222.12M | $219.67M | $211.69M | $205.26M | $197.43M |
| Total assets | $17.82B | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B |
| Current liabilities | $2.89B | $2.86B | $2.87B | $3.14B | $3.02B | $2.93B | $2.91B | $2.97B |
| Short-term debt | $112.49M | $117.18M | $112.65M | $109.20M | $62.92M | $182.44M | $178.65M | $270.87M |
| Long-term debt | $10.66B | $10.66B | $10.51B | $10.16B | $10.18B | $10.08B | $9.56B | $9.18B |
| Total debt | $10.77B | $10.78B | $10.63B | $10.27B | $10.25B | $10.26B | $9.74B | $9.45B |
| Total liabilities | $16.69B | $16.63B | $16.45B | $16.32B | $16.22B | $15.94B | $15.46B | $15.19B |
| Shareholders' equity | -$591.09M | -$765.10M | -$755.50M | -$651.08M | -$571.87M | -$369.63M | -$267.10M | $121.12M |
| Net debt | $10.27B | $10.11B | $9.98B | $9.60B | $9.45B | $9.46B | $9.21B | $8.57B |
| Shares outstanding | 63.40M | 63.95M | — | 68.55M | 70.98M | 74.22M | 77.28M | 80.54M |
| Cash flow statement | ||||||||
| Operating cash flow | $518.83M | $490.07M | $320.83M | $540.73M | $841.53M | $324.24M | $180.01M | $547.63M |
| Capital expenditure | $159.49M | $169.82M | $102.02M | $145.43M | $166.09M | $121.09M | $143.26M | $170.66M |
| Free cash flow | $359.34M | $320.25M | $218.81M | $395.30M | $675.44M | $203.15M | $36.75M | $376.97M |
| Investing cash flow | -$420.11M | -$194.25M | -$139.09M | -$163.13M | -$262.52M | -$67.17M | -$162.14M | -$247.97M |
| Financing cash flow | -$271.13M | -$270.19M | -$213.34M | -$414.52M | -$582.16M | $4.45M | -$382.54M | -$565.10M |
| Depreciation & amortization | $165.19M | $167.81M | $177.83M | $179.61M | $177.49M | $174.70M | $176.45M | $166.64M |
| Stock-based compensation | $29.19M | $26.03M | $28.16M | $38.39M | $38.99M | $32.81M | $29.76M | $27.40M |
| Share buybacks | $73.01M | $181.48M | $196.37M | $274.48M | $240.05M | $283.67M | $510.16M | $365.38M |
Free plan shows the latest 8 periods; Pro shows all 74 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.